Novartis | NVS - Interest Income


Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Bausch Health Companies USD 11M 1000K Jun/2026
Biogen USD 37.9M 700K Mar/2026
Canopy Growth CAD 3.86M 1.89M Mar/2026
Corcept Therapeutics USD 4.89M 537K Mar/2026
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 22M 4M Mar/2026
J&J USD 2.27 0.13 Jun/2026
Merck USD 35M 34M Mar/2026
Pacira USD 1.93M 365K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 77M 17M Jun/2026
Sanofi EUR 60M 54M Mar/2026
Supernus Pharmaceuticals USD 2.38M 359K Mar/2026
Zoetis USD 25M 1000K Dec/2025